Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Clinical Efficacy and Economic Evaluation of EC-MPS (Myfortic) in the Treatment of Relapse or Resistant Proliferative Lupus Nephritis
Brief Summary: To investigate the efficacy and safety of enteric-coated mycophenolate sodium (Myfortic) as compared to intravenous cyclophosphamide in the treatment of active nephritis. The primary outcomes are complete and partial renal remission, as assessed by renal function, urinary sediment and proteinuria in patients with International Society of Nephrology/ Renal Pathology Society (ISN/RPS) class III or IV lupus nephritis.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: mycophenolate sodium | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: cyclophosphamide | Intervention Type: DRUG; Name: mycophenolate sodium; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: cyclophosphamide; Assigned to Arm(s): 2
B: Arm Label: FK506+MMF; Type: ACTIVE_COMPARATOR; Interventions: Drug: Multitherapy | Intervention Type: DRUG; Name: Multitherapy; Assigned to Arm(s): FK506+MMF
C: Arm Label: Rituximab; Type: EXPERIMENTAL; Interventions: Drug: Rituximab, Drug: Mycophenolate mofetil, Drug: Methylprednisolone, Drug: Diphenhydramine, Drug: Acetaminophen, Drug: Prednisone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: Mycophenolate mofetil, Drug: Methylprednisolone, Drug: Diphenhydramine, Drug: Acetaminophen, Drug: Prednisone | Intervention Type: DRUG; Name: Rituximab; Assigned to Arm(s): Rituximab | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Mycophenolate mofetil; Assigned to Arm(s): Placebo, Rituximab | Intervention Type: DRUG; Name: Methylprednisolone; Assigned to Arm(s): Placebo, Rituximab | Intervention Type: DRUG; Name: Diphenhydramine; Assigned to Arm(s): Placebo, Rituximab | Intervention Type: DRUG; Name: Acetaminophen; Assigned to Arm(s): Placebo, Rituximab | Intervention Type: DRUG; Name: Prednisone; Assigned to Arm(s): Placebo, Rituximab
D: Arm Label: Abatacept 30 mg/kg+Corticosteroids+MMF; Type: EXPERIMENTAL; Interventions: Drug: Corticosteroids (prednisone or prednisolone), Drug: Abatacept, Drug: Mycophenolate mofetil (MMF) | Arm Label: Abatacept 10 mg/kg+Corticosteroids+MMF; Type: EXPERIMENTAL; Interventions: Drug: Corticosteroids (prednisone or prednisolone), Drug: Abatacept, Drug: Mycophenolate mofetil (MMF) | Arm Label: Placebo+Corticosteroids+MMF; Type: EXPERIMENTAL; Interventions: Drug: Corticosteroids (prednisone or prednisolone), Drug: Mycophenolate mofetil (MMF) | Arm Label: Abatacept 10mg/kg; Type: EXPERIMENTAL; Interventions: Drug: Abatacept | Intervention Type: DRUG; Name: Corticosteroids (prednisone or prednisolone); Assigned to Arm(s): Abatacept 10 mg/kg+Corticosteroids+MMF, Abatacept 30 mg/kg+Corticosteroids+MMF, Placebo+Corticosteroids+MMF | Intervention Type: DRUG; Name: Abatacept; Assigned to Arm(s): Abatacept 30 mg/kg+Corticosteroids+MMF | Intervention Type: DRUG; Name: Abatacept; Assigned to Arm(s): Abatacept 10 mg/kg+Corticosteroids+MMF | Intervention Type: DRUG; Name: Mycophenolate mofetil (MMF); Assigned to Arm(s): Abatacept 10 mg/kg+Corticosteroids+MMF, Abatacept 30 mg/kg+Corticosteroids+MMF, Placebo+Corticosteroids+MMF | Intervention Type: DRUG; Name: Abatacept; Assigned to Arm(s): Abatacept 10mg/kg

Answer: A